NPY and breast carcinoma: For example, primary tumors and metastatic sites were observed in breast cancer patients treated with a technetium-99 m labeled [F7, P34]-NPY (neuropeptide Y) conjugate, but no peptide uptake was observed in healthy individuals [7].